Abiopharma

🔍 EDGEMOND JAMES (Executive)

Company: UNITED THERAPEUTICS Corp (UTHR)

Report Date: 2026-04-16

Detailed Transactions and Holdings:

• Acquired 10,000 shares of Common Stock at $135.42 per share (Direct)
  Date: 2026-04-16 | Code: M | equity_swap_involved: false | shares_owned_after: 28,876.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 520 shares of Common Stock at $573.9146 per share (Direct)
  Date: 2026-04-16 | Code: S | equity_swap_involved: false | shares_owned_after: 28,356.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 1,680 shares of Common Stock at $574.733 per share (Direct)
  Date: 2026-04-16 | Code: S | equity_swap_involved: false | shares_owned_after: 26,676.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 789 shares of Common Stock at $575.6405 per share (Direct)
  Date: 2026-04-16 | Code: S | equity_swap_involved: false | shares_owned_after: 25,887.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 2,206 shares of Common Stock at $576.9149 per share (Direct)
  Date: 2026-04-16 | Code: S | equity_swap_involved: false | shares_owned_after: 23,681.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 2,085 shares of Common Stock at $577.8728 per share (Direct)
  Date: 2026-04-16 | Code: S | equity_swap_involved: false | shares_owned_after: 21,596.00 | transaction_form_type: 4 | Footnotes: F1, F6
• Sold 1,066 shares of Common Stock at $578.8269 per share (Direct)
  Date: 2026-04-16 | Code: S | equity_swap_involved: false | shares_owned_after: 20,530.00 | transaction_form_type: 4 | Footnotes: F1, F7
• Sold 1,454 shares of Common Stock at $579.6354 per share (Direct)
  Date: 2026-04-16 | Code: S | equity_swap_involved: false | shares_owned_after: 19,076.00 | transaction_form_type: 4 | Footnotes: F1, F8
• Sold 160 shares of Common Stock at $581.0825 per share (Direct)
  Date: 2026-04-16 | Code: S | equity_swap_involved: false | shares_owned_after: 18,916.00 | transaction_form_type: 4 | Footnotes: F1, F9
• Sold 40 shares of Common Stock at $581.64 per share (Direct)
  Date: 2026-04-16 | Code: S | equity_swap_involved: false | shares_owned_after: 18,876.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 10,000 shares of Stock Option at $135.42 per share (Derivative)
  Date: 2026-04-16 | Code: M | Expires: 2027-03-15 | Exercise: 2023-03-15 | equity_swap_involved: false | shares_owned_after: 82,500.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025.
• F2: This transaction was executed in multiple trades at prices ranging from $573.15 to $574.12. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F3: This transaction was executed in multiple trades at prices ranging from $574.22 to $575.19. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F4: This transaction was executed in multiple trades at prices ranging from $575.25 to $576.23. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F5: This transaction was executed in multiple trades at prices ranging from $576.30 to $577.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F6: This transaction was executed in multiple trades at prices ranging from $577.30 to $578.24. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F7: This transaction was executed in multiple trades at prices ranging from $578.32 to $579.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F8: This transaction was executed in multiple trades at prices ranging from $579.32 to $580.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F9: This transaction was executed in multiple trades at prices ranging from $580.62 to $581.45. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.